Sponsor Orphan
Orphan Drugs in Asia Pacific: the designation of pricing, financing and market access
A new report from the main drugs orphans in Asia and the Pacific: a description of the pricing, financing and market access focuses on five markets of developed countries in the region: Japan, South Korea, Taiwan, Singapore and Australia. Each has taken specific measures to promote development, recording and / or marketing treatments for rare diseases. Drugs of Singapore (Orphan Drug) Exemption Order 1991 was the first act to follow anywhere in the U.S. Orphan Drug Act, with the other four in Asia and the Pacific also measures to promote the EU orphan.
Rare diseases collectively are not so rare, in fact, 6-10% of people suffer from one to one time of life. Asia-Pacific region has about two thirds of the world population, and provide great potential for companies developing orphan drugs. But the clinical need that money does not mean enough for the diagnosis and treatment available.
The report describes the processes for obtaining orphan product designation, which can be omitted from the standard folder obtain marketing approval, and provides all the details and deadlines regulatory agencies. The emphasis is not on the register, but access to the market, for products as orphan medicinal products that often carry high price, ways to qualify for a refund or other sources of public funds.
Based on a extensive research, including on the ground in Tokyo and Seoul in November 2009 to capture the information, understanding and the latest trends, the report includes:
The incentives available to developers of orphan drugs.
How P & I of the work process specifically for drugs orphans.
The role of hypertension and risk sharing as a lever to get the refund.
When the plans for special funding works and how to access them.
13 case studies on peace and reconciliation story of 12 orphan drugs in five different countries.
How many patients are expected to contribute the cost of treatment.
Register designated and approved orphan drugs.
Comparisons between countries with policies on orphan drugs and others.
For more information please contact:
http://blogs.aarkstore.com/
From: Aarkstore Company
Contact: Neel
Email: press@aarkstore.com
URL: www.aarkstore.com
About the Author
Pushpanjali
Marketing Manager
contact@aarkstore.com
http://www.aarkstore.com
http://blogs.aarkstore.com
du ramadan ad (sponsor an orphan) 2007